S. Zarogiannis (Larissa , Greece), D. Bumbacea (Bucharest, Romania)
Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma
K. Lamote, J. Van Cleemput, K. Nackaerts, J. van Meerbeeck (Ghent, Kapelle-op-den-Bos, Leuven, Edegem, Belgium)
|   |
Role of fibulin-3 in the diagnosis of malignant mesothelioma
M. Agha, M. El-habashy, R. El-Shazly (Shebien-El Kom, Egypt)
|  |
Belgian prospective, multicenter, observational study of patients with malignant pleural mesothelioma treated with pemetrexed plus platinum
K. Nackaerts, M. Lambrechts, F. Bustin, L. Van Zandweghe, B. Colinet, M. Thomeer, J. F. Rosier, K. Kraaij, Y. D'yachkova (Leuven, Mechelen, Liège, Dendermonde, Charleroi, Diepenbeek, La Louvière, Belgium; Houten, Netherlands; Vienna, Austria)
| |
The effect of co-cancer morbidity on mortality in subjects with malignant mesothelioma - a register based study
O. Omland, M. Munk-Poulsen, M. Musleh, J. Hansen (Aalborg, Copenhagen, Denmark)
| |
Pleural mesothelioma: Our experience in 132 cases
E. Perez, M. Inchausti, L. Garcia, A. Sagarna, U. Jimenez, L. Martinez, B. Gomez, S. Castro, P. M. Ansola (Barakaldo, Spain)
| |
Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study
M. Korsic, S. Badovinac, D. Mursic, M. Roglic, M. Jakopovic, B. Cucevic (Zagreb, Croatia)
| |
Value of thoracoscopic pleural brush in the diagnosis of exudative pleural effusion
L. Shaaban, Y. Ahmed (Assiut, Egypt)
| |